Allergan (AGN) Receives Positive Swedish MPA Opinion for BELKYRA as Submental Fullness Treatment
Tweet Send to a Friend
Allergan plc (NYSE: AGN) announced that it has received a Positive Opinion from the Swedish Medical Products Agency (MPA) for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
